Register

Downloads / CME/CE Credit

Course Director & Faculty

Michael Postow, MD
Course Director and Presenter
Michael Postow, MD
Memorial Sloan Kettering Cancer Center
New York, New York
Marianne Davies, DNP, ACNP, AOCNP
Co-Presenter
Marianne Davies, DNP, ACNP, AOCNP
Yale School of Nursing
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut
Mario Sznol, MD
Co-Presenter
Mario Sznol, MD
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Location

Hyatt Regency Orlando
Florida B, Convention Level
9801 International Drive
Orlando, FL 32819

Agenda

6:30 PM: Registration and Dinner

7:00 PM: Welcome and Introduction

7:05 PM: From Molecular Basis to Clinical Application of Immune Checkpoint Blockade: What Do Clinicians Need to Know and Convey to Their Patients?

7:25 PM: Collaborative Approach is Key: Educating and Engaging Patients With the Clinical Team to Maximize the Benefits of Immunotherapy

7:40 PM: Timely Recognition and Effective Management of Immune-Related Adverse Effects: Current Guidelines and Algorithms

8:05 PM: Stories Behind the Science: Real-World Immuno-Oncology Lessons From the Front Lines of Patient Care

8:25 PM: Reflections and Conclusions

CME/CE Information

Three Key Reasons to Attend
Immuno-oncology is here to stay—are you prepared?
Activity Description & Educational Objectives

How can we make the most of immunotherapy as the new pillar of cancer care? This educational session will offer an essential immuno-oncology update to guide you in applying the evolving evidence to practice. Our experts will elucidate what to expect from the use of immune checkpoint blockade therapies, and highlight best practices for appropriate immune-related response assessment and effective management of immune-related adverse effects. Based on this foundation, strategies for patient education and engagement, as well as collaborative, team-based care will be discussed, which can help maximize the therapeutic potential of immunotherapies for the benefit of patients.

Upon completion of this activity, participants will be able to:

Target Audience

This activity has been designed to meet the educational needs of academic and community oncologists, research oncologists, hematologist-oncologists, oncology advanced practice clinicians, and other healthcare professionals involved in the integration of immuno-oncology approaches into treatment of patients with cancer.

Purpose Statement

The purpose of this activity is to improve the knowledge and competence of nurses concerning the treatment or management of patients with various solid tumors using novel immune-based therapies.

Requirements for Successful Completion

In order to receive credit, participants must attend the live activity and complete the request for credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME/CE credit. Statements of Credit are awarded upon completion of the request for credit at the end of the post-test.

Media: Symposium
Release and Expiration Date: Friday, February 24, 2017
Time to Complete: 90 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity for any amount during the past 12 months.

Course Director and Presenter

Michael Postow, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Co-Presenters

Marianne Davies, DNP, ACNP, AOCNP
Assistant Professor
Yale School of Nursing
Oncology Nurse Practitioner
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Mario Sznol, MD
Deputy Section Chief of Medical Oncology
Professor of Medicine
Co-Director, Yale SPORE in Skin Cancer
Co-Director, Melanoma Unit
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Disclaimer

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support
Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).

Providership

This CME/CE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported through educational grants from Bristol-Myers Squibb and Merck.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.